San Diego-centered Viking Therapeutics marked alone as a serious competitor in the weight loss drug marketplace in February just after revealing promising knowledge from a mid-stage demo of experimental drug VK2735, which recommended it rivaled—and outperformed—Novo and Lilly drugs when supplied for a weekly injection As well as in March the co